Thus, the molecular mechanisms of T2DM provide us with information about the impairment of insulin secretion, identifying the following pathological defects: pancreatic β-cell dysfunction and insulin resistance represented by abnormalities in insulin receptors. This evidence concerns the gene INS and type 2 diabetes mellitus.